Tectonic Therapeutic, Inc. (TECX)
(Delayed Data from NSDQ)
$17.19 USD
+0.54 (3.24%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $17.19 0.00 (0.00%) 5:52 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Income Statements
Fiscal Year end for Tectonic Therapeutic, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | -10 | 105 | 119 | 120 | 76 |
Income After Depreciation & Amortization | 10 | -105 | -119 | -120 | -76 |
Non-Operating Income | 2 | 0 | 0 | 1 | 3 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 13 | -106 | -119 | -120 | -73 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 12 | -106 | -119 | -120 | -73 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 12 | -106 | -119 | -120 | -73 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 11 | -104 | -117 | -119 | -75 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | 10 | -105 | -119 | -120 | -76 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 44.57 | 43.74 | 42.85 | 36.21 | 27.43 |
Diluted EPS Before Non-Recurring Items | -1.58 | -2.42 | -2.78 | -3.31 | -2.66 |
Diluted Net EPS (GAAP) | 0.27 | -2.42 | -2.78 | -3.31 | -2.66 |
Fiscal Year end for Tectonic Therapeutic, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 7.94 | 9.66 | 22.93 | -68.01 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -7.94 | -9.66 | -22.93 | 68.01 |
Non-Operating Income | NA | 1.13 | 1.25 | 1.36 | -0.53 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -6.81 | -8.41 | -21.58 | 67.48 |
Income Taxes | NA | 0.00 | 0.38 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -6.81 | -8.79 | -21.58 | 67.48 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -6.81 | -8.78 | -21.58 | 67.48 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 44.79 | 44.33 | 44.53 | 44.28 |
Diluted EPS Before Non-Recurring Items | NA | -0.15 | -0.20 | -0.44 | -0.37 |
Diluted Net EPS (GAAP) | NA | -0.15 | -0.20 | -0.48 | 1.52 |